3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide
|
|
- CAS-Nr.
- 1675248-19-7
- Englisch Name:
- 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide
- Synonyma:
- Tofacitinib-24;Tofacitinib Imp.Q;Tofatinib Impurity Q;Tofacitinib Impurity JJ;Tofacitinib Related Compound 7;Tofacitinib Citrate Impurity 05;Azilsartan medoxomil impurity333;2-cyanoacetic 4-methylbenzenesulfonic anhydride;1-Piperidinepropanamide, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R)-;1-Piperidinepropanamide, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R)-
- CBNumber:
- CB42666835
- Summenformel:
- C16H22N6O2
- Molgewicht:
- 330.39
- MOL-Datei:
- 1675248-19-7.mol
|
3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide Eigenschaften
- L?slichkeit
- DMSO (Slightly), Methanol (Slightly)
- Aggregatzustand
- Solid
- Farbe
- Off-White to Pale Orange
Sicherheit
3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Tofacitinib impurity L is an impurity of Tofacitinib (T528000), an enantiopure stereoisomer of the drug, Janus kinase 3(Jak3) inhibitor (CP-690,550) that has been found to inhibit selected members of the STE7 and STE20 subfamily of kinases.
3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 80)Lieferanten
1675248-19-7()Verwandte Suche:
- 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide
- Tofacitinib Imp.Q :3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide
- Tofacitinib-24
- Tofacitinib Citrate Impurity 05
- Tofacitinib Related Compound 7
- Tofacitinib Impurity JJ
- Tofacitinib impurity 18/3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide
- Tofacitinib Imp.Q
- 1-Piperidinepropanamide, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R)-
- Azilsartan medoxomil impurity333
- Tofatinib Impurity Q
- 1-Piperidinepropanamide, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3R,4R)-
- 2-cyanoacetic 4-methylbenzenesulfonic anhydride
- 1675248-19-7
- 2227195-31-5